Block Listing Application to AIM
Source: RNS
AIM: AXS
Euronext Amsterdam: AXS
ACCSYS TECHNOLOGIES PLC
("Accsys" or the "Company" or "Group")
Block Listing Application to AIM
Accsys, the fast-growing and eco-friendly company that combines chemistry and technology to create high performance, sustainable wood building products announces that application has been made to the London Stock Exchange for a block listing of 1,000,000 ordinary shares of €0.05 each in the Company ("New Ordinary Shares").
The block listing will be used to issue shares over time in connection with the Company's share plans, including satisfying outstanding options already issued under the 2013 LTIP plan, issued to the Company's Employee Benefit Trust in relation to employee share awards or the Company's Deferred Bonus Scheme. The New Ordinary Shares issued and admitted to trading under the block admission will rank equally with the existing Shares.
The New Ordinary Shares are expected to be admitted to trading on AIM on 24 August 2022. The Company does not hold any shares in treasury.
The Company will make six-monthly announcements of the utilisation of the block admission, in line with its obligations under AIM Rule 29.
Ends
For further information, please contact:
|
Accsys, Investor Relations Sarah Ogilvie |
ir@accsysplc.com |
|
Numis Securities (London) Oliver Hardy (NOMAD), Ben Stoop |
+44 (0) 20 7260 1000
|
|
Investec Bank plc (London) Carlton Nelson, Alex Wright
ABN AMRO (Amsterdam) Richard van Etten, Astrid Paeper
|
+44 (0) 20 7597 5970
+31 20 344 2000 |
|
FTI Consulting (London) Matthew O'Keeffe, Alex Le May, Cally Billimore |
+44 (0) 20 3727 1340 Accsys@fticonsulting.com
|
|
Off the Grid (Amsterdam) Frank Neervoort, Yvonne Derske |
+31 681 734 236
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
